NCT00114218: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer |
|
|
| Completed | 2 | 28 | US | Gemcitabine Hydrochloride, dFdC, dFdCyd, Docetaxel, TXT | Gynecologic Oncology Group, National Cancer Institute (NCI) | Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma | 07/10 | | | |
